Alert

Recommended Alerts

Sign Up For Alerts

Can They Really Do That? The Specter of Government-Authorized Infringement of Pharmaceutical Patents

The perception that pharmaceuticals in the United States are overpriced, and that patent rights are why, has been a recurrent political theme over the last several years. This view, along with the ongoing novel coronavirus pandemic, has caused some to consider whether the U.S. government should act to ensure affordable access to potentially life-saving medicines.

Read More

IRS Issues Final Regulations for Medical Device Excise Tax Effective January 1, 2013: Industry Continues to Seek Delay or Repeal

Practices: Life Sciences

Printer-Friendly Version

Cookie Settings